The association between cortisol:C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol
Received 29 April 2019
Accepted for publication 29 July 2019
Published 27 August 2019 Volume 2019:15 Pages 2467—2475
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Yuping Ning
Christopher F Sharpley,1 Vicki Bitsika,1 Mary E McMillan,1 Emmanuel Jesulola,2 Linda L Agnew1
1Brain-Behaviour Research Group, University of New England, Armidale, NSW 2351, Australia; 2Emergency Department, Bathurst Base Hospital, Bathurst, NSW 2795, Australia
Correspondence: Christopher F Sharpley
Brain-Behaviour Research Group, University of New England, Queen Elizabeth Drive, Armidale, NSW 2350, Australia
Tel +61 26 773 2596
Purpose: Hormonal and inflammatory factors have been suggested as potentially influencing depressive state and depressive symptoms, but rarely compared for their relative contribution to these states and to specific depressive symptoms. This study examined cortisol:C-reactive protein (CRP) ratio, plus cortisol and CRP separately, as correlates of global depression and fatigue-related depression.
Patients and methods: One hundred and twenty-six community volunteers from rural Australia provided saliva and serum samples, and also completed a depression inventory.
Results: There was a significant correlation between cortisol:CRP ratio and depression-related fatigue, and this resolved to the effects of CRP rather than cortisol. Most of the variance in this association came from patients who were “depressed”, and there were no significant gender associations.
Conclusion: Inflammation, rather than HPA-axis activity, was associated with depression-related fatigue, supporting a model that places inflammation as a contributor to one of the major symptoms and predictors of depression. Individualization of therapy for depression-related fatigue in chronically stressed or physically ill patients might benefit from future research into cytokine therapy.
Keywords: depression, fatigue, CRP, cortisol
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]